Sai Life Sciences opens new clean room block at its manufacturing campus
Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the opening of a new Clean Room block at its cGMP API & Intermediate Manufacturing campus in Bidar, India.
Sai Life Sciences, one of India’s fastest growing Contract Research,
Development & Manufacturing Organizations (CRDMOs), today announced
the opening of a new Clean Room block at its cGMP API & Intermediate
Manufacturing campus in Bidar, India.
Making the announcement, Krishna Kanumuri, CEO &
Managing Director of Sai Life Sciences said, “Over the last two years
we have been seeing an increase in projects involving commercial
products, not just for regulatory starting materials and intermediates,
but also final drug substances. This addition of latest generation clean
rooms to our facilities expands our capacity while adding versatility
to help serve the diverse needs of our customers.”
A notable aspect across all of the company’s infrastructure expansion
over the past two years has been to make all new facilities uniformly
capable of handling containment down to 1µg/m3. The new 8,500 sq. ft. Clean Room block is the newest addition to this list. Located in the Bidar Manufacturing Campus of the company, it has the following features:
• Four ISO-8 (Class 100,000) Clean Rooms operating at containment level of 1µg/m3 across the operation
• Four parallel crystallizer lines with complete segregation of AHU
•
Five versatile dissolution reactors capable of handling various
reactions, including if crystallization step is in situ with reaction
•
Latest generation Wonderware automation which allows fine ramp control /
distillation control to handle critical cooling crystallization and
evaporative crystallization
• Versatile sizes of filtration, drying equipment (Filter dryers, Peeler centrifuge, Nauta dryer)
• Various material of construction (SS316, Hastelloy and Glass-lined).
• Separate line for size reduction.
• “Bubble design” with separate gowning / de-gowning areas and airlocks to enable multi-product handling.
Sai Life Sciences began a process of organizational transformation in 2019 reinventing itself as a new generation global CDMO. Through this initiative, named Sai Nxt,
the company is investing over US$ 150M (> INR 1000 Cr) to expand and
upgrade its R&D and manufacturing facilities, induct top-notch
global scientific and leadership talent, strengthen automation and data
systems, and above all raise the bar for safety, quality and customer
focus.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance